BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27130061)

  • 1. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
    Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
    Min LA; Vogel WV; Lahaye MJ; Maas M; Donswijk ML; Vegt E; Kusters M; Zijlmans HJ; Jóźwiak K; Roberti S; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2019 Dec; 29(12):6900-6910. PubMed ID: 31119418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of
    Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y
    Cancer Imaging; 2020 Oct; 20(1):75. PubMed ID: 33092631
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
    Kim DH; Kim SJ
    Clin Imaging; 2020 Sep; 65():100-107. PubMed ID: 32387798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
    Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A;
    Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple metabolic parameters and visual assessment of
    Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
    Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
    Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
    Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
    Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of
    Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H
    Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Einerhand SMH; van Gennep EJ; Mertens LS; Hendricksen K; Donswijk ML; van der Poel HG; van Rhijn BWG
    Curr Opin Urol; 2020 Sep; 30(5):654-664. PubMed ID: 32701719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate timing of surveillance intervals with whole-body
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Eur J Radiol; 2019 Sep; 118():75-80. PubMed ID: 31439262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
    Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
    Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
    Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
    J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
    Goel S; Aggarwal A; Iqbal A; Gupta M; Rao A; Singh S
    Eur J Surg Oncol; 2020 Sep; 46(9):1711-1716. PubMed ID: 32331985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of
    Zhang Z; Zheng B; Chen W; Xiong H; Jiang C
    Exp Ther Med; 2021 Feb; 21(2):164. PubMed ID: 33456531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review.
    van Uden DJP; Prins MW; Siesling S; de Wilt JHW; Blanken-Peeters CFJM; Aarntzen EHJG
    Crit Rev Oncol Hematol; 2020 Jul; 151():102943. PubMed ID: 32416347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidentally found parotid gland lesion in
    Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
    BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.